{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:27:22Z","timestamp":1762543642128,"version":"3.44.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ijcard.2022.06.026","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T11:25:09Z","timestamp":1655292309000},"page":"119-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Gaps of evidence in pulmonary arterial hypertension"],"prefix":"10.1016","volume":"364","author":[{"given":"Carmine Dario","family":"Vizza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Ghio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Badagliacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Manzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Scelsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Argiento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"D'Alto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.ijcard.2022.06.026_bb0005","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMra2000348","article-title":"Pulmonary arterial hypertension","volume":"385","author":"Hassoun","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2022.06.026_bb0010","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.ijcard.2022.06.026_bb0015","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1183\/09031936.00145608","article-title":"Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review","volume":"34","author":"Kovacs","year":"2009","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.ijcard.2022.06.026_bb0020","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/ejhf.1570","article-title":"Mildly increased pulmonary arterial pressure: a new disease entity or just a marker of poor prognosis?","volume":"21","author":"Kovacs","year":"2019","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.ijcard.2022.06.026_bb0025","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction","volume":"3","author":"Borlaug","year":"2010","journal-title":"Circ. Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2022.06.026_bb0030","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jacc.2011.06.076","article-title":"Pulmonary pressures and death in heart failure: a community study","volume":"59","author":"Bursi","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2022.06.026_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.chest.2016.08.1439","article-title":"Clinical relevance of fluid challenge in patients evaluated for pulmonary hypertension","volume":"151","author":"D\u2019Alto","year":"2017","journal-title":"Chest."},{"issue":"5","key":"10.1016\/j.ijcard.2022.06.026_bb0040","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1378\/chest.127.5.1531","article-title":"Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation","volume":"127","author":"Thabut","year":"2005","journal-title":"Chest."},{"issue":"3","key":"10.1016\/j.ijcard.2022.06.026_bb0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.2107027","article-title":"National Emphysema Treatment Trial (NETT) group. Hemodynamic characterization of patients with severe emphysema","volume":"166","author":"Scharf","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.ijcard.2022.06.026_bb0050","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1378\/chest.06-1466","article-title":"Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis","volume":"131","author":"Hamada","year":"2007","journal-title":"Chest."},{"issue":"3","key":"10.1016\/j.ijcard.2022.06.026_bb0055","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1378\/chest.06-2485","article-title":"Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis","volume":"131","author":"Nathan","year":"2007","journal-title":"Chest."},{"issue":"4","key":"10.1016\/j.ijcard.2022.06.026_bb0060","doi-asserted-by":"crossref","first-page":"1701197","DOI":"10.1183\/13993003.01197-2017","article-title":"Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis","volume":"51","author":"Coghlan","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"20","key":"10.1016\/j.ijcard.2022.06.026_bb0065","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1161\/CIRCULATIONAHA.108.838698","article-title":"Age-associated increases in pulmonary artery systolic pressure in the general population","volume":"119","author":"Lam","year":"2009","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.ijcard.2022.06.026_bb0070","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1086\/674756","article-title":"Clinical characterization and survival of patients with borderline elevation in pulmonary artery pressure","volume":"3","author":"Heresi","year":"2013","journal-title":"Pulm. Circ."},{"issue":"13","key":"10.1016\/j.ijcard.2022.06.026_bb0075","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/CIRCULATIONAHA.115.020207","article-title":"Association of Borderline Pulmonary Hypertension with Mortality and Hospitalization in a large patient cohort: insights from the veterans affairs clinical assessment, reporting, and tracking program","volume":"133","author":"Maron","year":"2016","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.ijcard.2022.06.026_bb0080","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1164\/rccm.201706-1215OC","article-title":"Mild elevation of pulmonary arterial pressure as a predictor of mortality","volume":"197","author":"Douschan","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"Suppl K","key":"10.1016\/j.ijcard.2022.06.026_bb0085","doi-asserted-by":"crossref","first-page":"K4","DOI":"10.1093\/eurheartj\/suz211","article-title":"The revised definition of pulmonary hypertension: exploring the impact on patient management","volume":"21","author":"Simonneau","year":"2019","journal-title":"Eur. Heart J. Suppl."},{"issue":"4","key":"10.1016\/j.ijcard.2022.06.026_bb0090","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.37838","article-title":"Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension","volume":"65","author":"Valerio","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.ijcard.2022.06.026_bb0095","doi-asserted-by":"crossref","first-page":"1700578","DOI":"10.1183\/13993003.00578-2017","article-title":"An official European Respiratory Society statement: pulmonary haemodynamics during exercise","volume":"50","author":"Kovacs","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.ijcard.2022.06.026_bb0100","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1183\/13993003.01684-2015","article-title":"Resting pulmonary artery pressure of 21-24\u00a0mmHg predicts abnormal exercise haemodynamics","volume":"47","author":"Lau","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.ijcard.2022.06.026_bb0105","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1183\/13993003.00397-2016","article-title":"Exercise pulmonary haemodynamics: a test in search of purpose [published correction appears in Eur Respir J. 2016 Jul;48(1):285]","volume":"47","author":"Coghlan","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.ijcard.2022.06.026_bb0110","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1183\/13993003.00990-2016","article-title":"Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis","volume":"48","author":"Stamm","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.ijcard.2022.06.026_bb0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13075-019-1981-0","article-title":"Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)","volume":"21","author":"Pan","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.ijcard.2022.06.026_bb0120","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1002\/art.34614","article-title":"Brief report: effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: a prospective single-center, open-label pilot study","volume":"64","author":"Saggar","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.ijcard.2022.06.026_bb0125","doi-asserted-by":"crossref","first-page":"1800458","DOI":"10.1183\/13993003.00458-2018","article-title":"Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease","volume":"52","author":"Guth","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2022.06.026_bb0130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D\u2019Alonzo","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2022.06.026_bb0135","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1378\/chest.11-0676","article-title":"The REVEAL registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension","volume":"141","author":"Benza","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2022.06.026_bb0140","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","article-title":"Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score calculator 2.0 and comparison with ESC\/ERS-based risk assessment strategies","volume":"156","author":"Benza","year":"2019","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ijcard.2022.06.026_bb0145","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.chest.2020.08.2069","article-title":"Development and validation of an abridged version of the REVEAL 2.0 risk score calculator, REVEAL lite 2, for use in patients with pulmonary arterial hypertension","volume":"159","author":"Benza","year":"2021","journal-title":"Chest."},{"key":"10.1016\/j.ijcard.2022.06.026_bb0150","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. The joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2022.06.026_bb0155","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1093\/eurheartj\/ehx257","article-title":"A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension","volume":"39","author":"Kylhammar","year":"2018","journal-title":"Eur. Heart J."},{"year":"2022","series-title":"Risk Assessment, Prognosis and Guideline Implementation in Pulmonary Arterial Hypertension","author":"Boucly","key":"10.1016\/j.ijcard.2022.06.026_bb0160"},{"issue":"2","key":"10.1016\/j.ijcard.2022.06.026_bb0165","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00740-2017","article-title":"Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model","volume":"50","author":"Hoeper","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2022.06.026_bb0170","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s12325-019-01030-4","article-title":"Assessment of risk of disease progression in pulmonary arterial hypertension: insights from an international survey of clinical practice","volume":"36","author":"Simons","year":"2019","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ijcard.2022.06.026_bb0175","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1164\/rccm.201806-1160ST","article-title":"Assessment of right ventricular function in the research setting: knowledge gaps and pathways forward. An official American Thoracic Society research statement","volume":"198","author":"Lahm","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcard.2022.06.026_bb0180","first-page":"56","article-title":"A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension","author":"Ghio","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2022.06.026_bb0185","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006984","article-title":"Clinical utility and prognostic value of right atrial function in pulmonary hypertension","volume":"11","author":"Alenezi","year":"2018","journal-title":"Circ. Cardiovasc. Imag."},{"issue":"1","key":"10.1016\/j.ijcard.2022.06.026_bb0190","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jcmg.2020.08.017","article-title":"Right ventricular strain curve morphology and outcome in idiopathic pulmonary arterial hypertension","volume":"14","author":"Badagliacca","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2022.06.026_bb0195","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3390\/diagnostics10110857","article-title":"Galectin-3 plasma levels are associated with risk profiles in pulmonary arterial hypertension","volume":"10","author":"Scelsi","year":"2020","journal-title":"Diagnostics (Basel)."},{"key":"10.1016\/j.ijcard.2022.06.026_bb0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S2213-2600(15)00544-5","article-title":"BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis","volume":"4","author":"Evans","year":"2016","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2022.06.026_bb0205","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S2213-2600(18)30409-0","article-title":"Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis","volume":"7","author":"Rhodes","year":"2019","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2022.06.026_bb0210","doi-asserted-by":"crossref","DOI":"10.1177\/20458940211037275","article-title":"BMPR2 mutations and response to inhaled or parenteral prostanoids: a case series","volume":"11","author":"Scelsi","year":"2021","journal-title":"Pulm. Circ."},{"issue":"2","key":"10.1016\/j.ijcard.2022.06.026_bb0215","doi-asserted-by":"crossref","first-page":"2000008","DOI":"10.1183\/13993003.00008-2020","article-title":"Risk stratification in pulmonary arterial hypertension using Bayesian analysis","volume":"56","author":"Kanwar","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2022.06.026_bb0220","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijcard.2018.08.085","article-title":"General measures and supportive therapy for pulmonary arterial hypertension: updated recommendations from the Cologne consensus conference 2018","volume":"272S","author":"Gr\u00fcnig","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2022.06.026_bb0225","doi-asserted-by":"crossref","first-page":"1801889","DOI":"10.1183\/13993003.01889-2018","article-title":"Risk stratification and medical therapy of pulmonary arterial hypertension","volume":"53","author":"Gali\u00e8","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.ijcard.2022.06.026_bb0230","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.healun.2017.08.009","article-title":"Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension","volume":"37","author":"Badagliacca","year":"2018","journal-title":"J. Heart Lung Transplant."},{"issue":"4","key":"10.1016\/j.ijcard.2022.06.026_bb0235","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.healun.2011.12.011","article-title":"Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: the impact of late referral","volume":"31","author":"Badagliacca","year":"2012","journal-title":"J. Heart Lung Transplant."},{"issue":"1","key":"10.1016\/j.ijcard.2022.06.026_bb0240","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40256-017-0262-z","article-title":"Targeting the prostacyclin pathway with Selexipag in patients with pulmonary arterial hypertension receiving double combination therapy: insights from the randomized controlled GRIPHON study","volume":"18","author":"Coghlan","year":"2018","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"3","key":"10.1016\/j.ijcard.2022.06.026_bb0245","doi-asserted-by":"crossref","first-page":"1602425","DOI":"10.1183\/13993003.02425-2016","article-title":"RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors","volume":"50","author":"Hoeper","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.ijcard.2022.06.026_bb0250","first-page":"573","article-title":"REPLACE investigators. Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial. Lancet","volume":"9","author":"Hoeper","year":"2021","journal-title":"Respir. Med."},{"key":"10.1016\/j.ijcard.2022.06.026_bb0255","first-page":"2102311","article-title":"COMPERA 2.0: A refined 4-strata risk assessment model for pulmonary arterial hypertension","author":"Hoeper","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.ijcard.2022.06.026_bb0260","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/17476348.2018.1515629","article-title":"The importance of right ventricular function in patients with pulmonary arterial hypertension","volume":"12","author":"Badagliacca","year":"2018","journal-title":"Exp. Rev. Respir. Med."},{"issue":"301","key":"10.1016\/j.ijcard.2022.06.026_bb0265","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijcard.2019.10.043","article-title":"The importance of right ventricular evaluation in risk assessment and therapeutic strategies: raising the bar in pulmonary arterial hypertension","volume":"15","author":"Badagliacca","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2022.06.026_bb0270","article-title":"Aggressive afterload lowering to improve the RV: a new target for medical therapy in PAH?","author":"Vizza","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322009251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322009251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:58:41Z","timestamp":1759093121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527322009251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":54,"alternative-id":["S0167527322009251"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.06.026","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gaps of evidence in pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}